Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 7 | 2022 | 3646 | 0.710 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 2014 | 0.400 |
Why?
|
| Humerus | 1 | 2010 | 272 | 0.310 |
Why?
|
| Gene Knock-In Techniques | 4 | 2016 | 419 | 0.300 |
Why?
|
| Transplantation, Heterologous | 1 | 2016 | 2394 | 0.300 |
Why?
|
| Osteosarcoma | 1 | 2010 | 909 | 0.230 |
Why?
|
| Antigens, CD34 | 2 | 2016 | 656 | 0.220 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2019 | 225 | 0.170 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2022 | 308 | 0.160 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 2567 | 0.150 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18293 | 0.140 |
Why?
|
| Cytokines | 3 | 2016 | 7421 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2019 | 634 | 0.140 |
Why?
|
| Benzothiazoles | 1 | 2017 | 246 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2018 | 228 | 0.130 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2016 | 157 | 0.120 |
Why?
|
| Pyrimidinones | 1 | 2017 | 384 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2016 | 340 | 0.120 |
Why?
|
| DNA Damage | 1 | 2023 | 2457 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2022 | 2485 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2023 | 2942 | 0.100 |
Why?
|
| Antigens, Differentiation | 1 | 2016 | 919 | 0.100 |
Why?
|
| Receptors, Immunologic | 2 | 2016 | 1415 | 0.090 |
Why?
|
| Neutropenia | 1 | 2016 | 893 | 0.090 |
Why?
|
| Autophagy | 1 | 2018 | 1351 | 0.080 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 1774 | 0.080 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2010 | 476 | 0.080 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2012 | 422 | 0.080 |
Why?
|
| Thrombocytopenia | 1 | 2016 | 1171 | 0.080 |
Why?
|
| Cell Line, Tumor | 6 | 2023 | 17075 | 0.070 |
Why?
|
| ras Proteins | 1 | 2012 | 1053 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2016 | 3401 | 0.070 |
Why?
|
| Mutation | 5 | 2023 | 30198 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 13451 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 5696 | 0.060 |
Why?
|
| Dendritic Cells | 1 | 2016 | 2747 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5337 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2010 | 2505 | 0.060 |
Why?
|
| Mice | 7 | 2023 | 81819 | 0.050 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2006 | 384 | 0.050 |
Why?
|
| Inflammation | 1 | 2022 | 10850 | 0.050 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2023 | 104 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2023 | 312 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 5783 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2023 | 416 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2022 | 23601 | 0.050 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2023 | 212 | 0.050 |
Why?
|
| Interferon Regulatory Factors | 1 | 2022 | 271 | 0.040 |
Why?
|
| Animals | 8 | 2023 | 168764 | 0.040 |
Why?
|
| Diphenylamine | 1 | 2019 | 49 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 4520 | 0.040 |
Why?
|
| Humans | 15 | 2023 | 765968 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11868 | 0.040 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2018 | 13 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2006 | 2864 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 13648 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2019 | 330 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 479 | 0.040 |
Why?
|
| Indazoles | 1 | 2019 | 303 | 0.040 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2019 | 639 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2021 | 837 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2022 | 1144 | 0.030 |
Why?
|
| RNA | 1 | 2006 | 2717 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 1679 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2019 | 820 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2017 | 425 | 0.030 |
Why?
|
| Oncogenes | 1 | 2022 | 1235 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2019 | 657 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2023 | 2920 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2019 | 1749 | 0.030 |
Why?
|
| Thrombomodulin | 1 | 2016 | 107 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 2016 | 444 | 0.030 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2023 | 1608 | 0.030 |
Why?
|
| Thrombopoietin | 1 | 2016 | 225 | 0.030 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2018 | 497 | 0.030 |
Why?
|
| Benzamides | 1 | 2019 | 1377 | 0.030 |
Why?
|
| Pyrazines | 1 | 2019 | 1204 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 1885 | 0.030 |
Why?
|
| Antigens, CD1 | 1 | 2016 | 435 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2023 | 2844 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 1490 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 3051 | 0.020 |
Why?
|
| DNA Repair | 1 | 2021 | 2048 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2016 | 1617 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3608 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2016 | 2669 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2016 | 2630 | 0.020 |
Why?
|
| Cell Separation | 1 | 2016 | 1718 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 40065 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2016 | 2195 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2016 | 5753 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5747 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2017 | 5379 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 996 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2016 | 2058 | 0.020 |
Why?
|
| Oligoribonucleotides | 1 | 2006 | 46 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2023 | 8611 | 0.020 |
Why?
|
| Rabies virus | 1 | 2006 | 37 | 0.020 |
Why?
|
| RNA Caps | 1 | 2006 | 72 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 1314 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10729 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 4392 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5881 | 0.020 |
Why?
|
| RNA, Double-Stranded | 1 | 2006 | 292 | 0.010 |
Why?
|
| Interferon-beta | 1 | 2006 | 346 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11022 | 0.010 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2006 | 368 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 1761 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 9550 | 0.010 |
Why?
|
| Cytosol | 1 | 2006 | 885 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2018 | 12768 | 0.010 |
Why?
|
| Phosphates | 1 | 2006 | 763 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 2006 | 910 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2012 | 2531 | 0.010 |
Why?
|
| Ligands | 1 | 2006 | 3273 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 22332 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2006 | 1797 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 5743 | 0.010 |
Why?
|
| Virus Replication | 1 | 2006 | 2447 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 9601 | 0.010 |
Why?
|
| Monocytes | 1 | 2006 | 2595 | 0.010 |
Why?
|
| Middle Aged | 1 | 2010 | 223009 | 0.010 |
Why?
|
| Apoptosis | 1 | 2012 | 9514 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 8278 | 0.010 |
Why?
|
| Child | 1 | 2023 | 80564 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2016 | 41649 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 7599 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 15543 | 0.010 |
Why?
|
| Male | 1 | 2010 | 363698 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 18973 | 0.010 |
Why?
|
| Adult | 1 | 2023 | 223044 | 0.000 |
Why?
|
| Female | 1 | 2019 | 396112 | 0.000 |
Why?
|
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_